ARCHIVE

• CORPORATE ROUNDUP NEWS IN BRIEF
  February 10, 2003

• 100% Acquisition to Eliminate Wall Between Merck, Banyu
  February 10, 2003

• Chuikyo to Discuss Additional NHI Price Cuts for Long-listed Original Drugs
  February 10, 2003

• GSK, Sankyo Agree to Copromote Type 2 Diabetes Drug, Rosiglitazone
  February 10, 2003

• Korosho to Start Disease-related Protein Analysis Project
  February 10, 2003

• Teijin, Kyorin to Strengthen Business in Respiratory Field
  February 10, 2003

• Bio-derived Products Total 189 Ingredients
  February 10, 2003

• Aventis to Transfer Suvenyl Manufacturing Rights to Chugai
  February 10, 2003

• PFSB to Review Current Quality Reevaluation Program
  February 10, 2003

• DMS Seminar Discusses How to Build Collaboration in Distribution
  February 10, 2003

• Mochida's Drug Discovery Research Institute to Become Independent
  February 10, 2003

• REGULATORY NEWS IN BRIF
  February 10, 2003

• voluntary Agreement on Precautions in Use of OTC Drugs Revised
  February 10, 2003

• Sales of Seroquel to Reach \9.3 Bil. for FY2002
  February 10, 2003

• Korosho to Determine Lump-sum Fees According to Length of Hospital Stay
  February 10, 2003

• ACCJ Seminar Focuses on Early Discovery, Diagnosis of Breast Cancer
  February 10, 2003

• Osaka Has Largest Dormant Market for Drug Dispensing Services: NRI Report
  February 10, 2003

• Over 70% of Public Wants Equal Healthcare Regardless of Income: JMA Survey
  February 10, 2003

• Boston Scientific Ties Up with Advanced Neuromodulation Systems
  February 10, 2003

• Taisho Toyama Pharm Aims at No. 1 in Infections, Orthopedics
  February 10, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 620
• 621
• 622
• 623
• 624
• 625
• 626
• 627
• 628
• …
• Next ›
• 最終 »